Denizbank A.S.

◆英語タイトル:Denizbank A.S. - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY3305
◆発行会社(調査会社):MarketLine
◆発行日:2019
◆ページ数:39
◆レポート言語:
◆レポート形式:PDF
◆納品方法:E
◆対象地域:
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Single UserUSD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site LicenseUSD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide LicenseUSD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Denizbank A.S. – Strategy, SWOT and Corporate Finance Report
Summary

Denizbank A.S. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

Denizbank A.S. (Denizbank) a subsidiary of Sberbank Rossii, is a banking and other financial products and services provider. The bank provides a range of corporate, public, retail, commercial, small and medium enterprises (SMEs) and agricultural banking products and services. Its portfolio of products include saving accounts, deposits, credit cards, debit cards, commercial cards, mortgage loans, personal loans, agriculture loans, commercial loans, home loans, car loans, and investment products. Denizbank also provides insurance solutions such as life insurance, car insurance, property insurance, engineering insurance, personal insurance, accident insurance, travel insurance and business insurance. In addition, it offers cash management, investment consulting, wealth management, treasury management, factoring, leasing and internet banking services. These products and services are offered to individuals and corporate clients through a network of its branches, ATMs, and foreign subsidiaries. Denizbank is headquartered in Istanbul, Turkey.

Scope

- Detailed information on Denizbank A.S. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Denizbank A.S. in the form of a SWOT analysis
- An in-depth view of the business model of Denizbank A.S. including a breakdown and examination of key business segments
- Intelligence on Denizbank A.S.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Denizbank A.S., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Denizbank A.S. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Denizbank A.S. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Denizbank A.S.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Denizbank A.S.: Company Overview
Denizbank A.S.: Overview and Key Facts
Denizbank A.S.: Overview
Denizbank A.S.: Key Facts
Denizbank A.S.: Key Employees
Denizbank A.S.: Key Employee Biographies
Denizbank A.S.: Major Products and Services
Denizbank A.S.: Company History
Denizbank A.S.: Management Statement
Denizbank A.S.: Locations and Subsidiaries
Denizbank A.S.: Key Competitors
Denizbank A.S.: Company Analysis
Denizbank A.S.: Business Description
Denizbank A.S.: SWOT Analysis
Denizbank A.S.: SWOT Overview
Denizbank A.S.: Strengths
Denizbank A.S.: Weaknesses
Denizbank A.S.: Opportunities
Denizbank A.S.: Threats
Denizbank A.S.: Corporate Financial Deals Activity
Denizbank A.S.: Financial Deals Overview
Denizbank A.S.: Top Deals 2015 – 2019YTD*
Denizbank A.S.: Private Equity and Ownership
Denizbank A.S.: Recent Developments
Denizbank A.S.: News and Events Summary
Denizbank A.S.: Contracts
Denizbank A.S.: Financial Deals
Denizbank A.S.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Denizbank A.S.: Key Facts
Table 2: Denizbank A.S.: Key Employees
Table 3: Denizbank A.S.: Company History
Table 4: Denizbank A.S.: Locations and Subsidiaries
Table 5: Denizbank A.S.: Key Competitors
Table 6: Denizbank A.S.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Denizbank A.S.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 8: Denizbank A.S.: Top Deals 2015 - 2019YTD*
Table 9: Denizbank A.S.: Private Equity and Ownership Volume and Value Trend (2015 - YTD*2019)
Table 10: Denizbank A.S.: Private Equity and Ownership Volume by Deal Type (2015 - YTD*2019)
Table 11: Denizbank A.S.: News and Events Summary
Table 12: Denizbank A.S.: Contracts
Table 13: Denizbank A.S.: Financial Deals
Table 14: Denizbank A.S.: Strategy and Operations

★海外企業調査レポート[Denizbank A.S.]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Urban Outfitters Inc:戦略・SWOT・企業財務分析
    Urban Outfitters Inc - Strategy, SWOT and Corporate Finance Report Summary Urban Outfitters Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • ESSA Pharma Inc (EPI)-製薬・医療分野:企業M&A・提携分析
    Summary Essa Pharma Inc (Essa Pharma) is a clinical-stage pharmaceutical company that carries out the development of small molecule drugs for the treatment castration-resistant prostate cancer (CRPC). The company’s lead product candidate, EPI-506, disrupts androgen receptor (AR) transcriptional acti …
  • Novo Nordisk AS (NOVO B)-製薬・医療分野:企業M&A・提携分析
    Summary Novo Nordisk A/S (Novo Nordisk), a subsidiary of Novo A/S discovers, develops and manufactures innovative biological medicines. It focuses at developing drugs for treating diabetes and other serious chronic conditions including hemophilia, growth disorders and obesity. The company’s product …
  • Taikisha Ltd
    Taikisha Ltd - Strategy, SWOT and Corporate Finance Report Summary Taikisha Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • DSG Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary DSG Inc (DSG) is a provider of eClinical software solutions. The company offers software products such as eCaseLink EDC, eClinDirect CTMS, eCaseLink.Me ePRO, DSG Drug Safety, eCaseLink IRT, DSG Designer, CaseXport, CaseView Imaging, and others. Its services include data management, technolog …
  • Thornton & Ross Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Thornton & Ross Ltd (Thornton & Ross), a subsidiary of Stada Arzneimittel AG is a supplier of medicines and healthcare products. The company offers over the counter pharmaceutical products. It also manufactures pharmaceutical creams, liquids and semi-solids. Thornton & Ross’ products compris …
  • Erytech Pharma SA (ERYP):製薬・医療:M&Aディール及び事業提携情報
    Summary Erytech Pharma SA (Erytech) is a clinical-stage biopharmaceutical company that provides development of therapies for rare forms of cancer and orphan diseases. The company develops pipeline of product candidates through its proprietary ERYCAPS platform. It offers product candidates which are …
  • Walgreens Boots Alliance, Inc.:企業の戦略・SWOT・財務情報
    Walgreens Boots Alliance, Inc. - Strategy, SWOT and Corporate Finance Report Summary Walgreens Boots Alliance, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Sacmi Imola S.C. :企業の戦略・SWOT・財務情報
    Sacmi Imola S.C. - Strategy, SWOT and Corporate Finance Report Summary Sacmi Imola S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Windtree Therapeutics Inc (WINTD):企業の財務・戦略的SWOT分析
    Windtree Therapeutics Inc (WINTD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • SciClone Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary SciClone Pharmaceuticals Inc (SciClone), a subsidiary of Silver Biotech Investment Ltd, develops and commercializes products for the treatment of cancer, cardiovascular disorders and infectious diseases. The company’s lead product, Zadaxin (thymalfasin) is an immunostimulatory agent indicate …
  • Taisho Pharmaceutical Holdings Co Ltd:企業の戦略・SWOT・財務情報
    Taisho Pharmaceutical Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Taisho Pharmaceutical Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • NextEra Energy Inc (NEE):電力:M&Aディール及び事業提携情報
    Summary NextEra Energy, Inc. (NEE), formerly FPL Group, Inc., is an electric power and energy infrastructure company that generates, transmits and distributes electricity together with its subsidiaries. The company generates power through various sources such as nuclear, coal, oil and natural gas-fi …
  • NVIDIA Corp (NVDA):企業の財務・戦略的SWOT分析
    NVIDIA Corp (NVDA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • TBC Corp:企業の戦略・SWOT・財務情報
    TBC Corp - Strategy, SWOT and Corporate Finance Report Summary TBC Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Sunkist Growers, Inc.:企業の戦略的SWOT分析
    Sunkist Growers, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • TechnoPhage SA-製薬・医療分野:企業M&A・提携分析
    Summary TechnoPhage SA (TechnoPhage) is a biotechnology company that concentrates on research and development of new molecules. The company conducts research and development of new products based on unique properties of bacteriophages. It also conducts contract research and development services for …
  • Trade Union Cooperative Insurance Company:企業の戦略・SWOT・財務情報
    Trade Union Cooperative Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Trade Union Cooperative Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Nihon Kohden Corporation:企業の戦略・SWOT・財務分析
    Nihon Kohden Corporation - Strategy, SWOT and Corporate Finance Report Summary Nihon Kohden Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • AFT Pharmaceuticals Pty Ltd-製薬・医療分野:企業M&A・提携分析
    Summary AFT Pharmaceuticals Pty Ltd (AFT Pharmaceuticals) is a manufacturer and distributor medical products. The company provides prescription and non-prescription products. Its products include moisturizers, calcium supplements, scalp ointments, eye drops, cracked heel creams, iron and folic acid …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆